Outcomes in United States Veterans on Insulin Pumps Following Rapid Deployment of Telehealth Care
Authors' conclusion
VA telehealth expansion during the COVID-19 pandemic was associated with disruptions in care delivery, but the percentage of VIPs with adverse diabetes outcomes did not increase.
Study context
- Population
- US Veterans on insulin pumps (VIPs), VA care, October 1, 2018 to September 30, 2021
- Participants
- 11,758 veterans
- Exposure
- Pandemic quarters vs pre-pandemic
- Outcome
- Changes in VA care delivery and VIP outcomes
Methodological detailsmixed effects logistic regression
- Mixed effects logistic regression
Main finding
As reported in the abstract
Adjusted odds of diabetes specialty care appointment delays increased, first pandemic quarter
31%
Adjusted odds of diabetes specialty care appointment delays increased, subsequent pandemic quarters
44%
Adjusted odds of completing HbA1c testing decreased, first pandemic quarter
75%
Adjusted odds of completing HbA1c testing decreased, subsequent pandemic quarters
23%
Observational data: associations, not effects.
Original publication
Outcomes in United States Veterans on Insulin Pumps Following Rapid Deployment of Telehealth Care. Diabetes Technol Ther. Published 23 January 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →